Voleon Capital Management’s Pfizer PFE Stock Holding History

Voleon Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$479K	Buy	17,061 +969	+6%	+$25.8K	0.01%	584
2025 Q4	$401K	Sell	16,092 -153,602	-91%	-$3.87M	0.01%	621
2025 Q3	$4.32M	Buy	169,694 +104,364	+160%	+$2.58M	0.11%	192
2025 Q2	$1.58M	Sell	65,330 -97,594	-60%	-$2.28M	0.09%	203
2025 Q1	$4.13M	Buy	162,924 +83,015	+104%	+$2.17M	0.32%	79
2024 Q4	$2.12M	Buy	+79,909	New	+$2.17M	0.16%	133
2021 Q1	–	Sell	-343,000	Closed	-$12.6M	–	27
2020 Q4	$12.6M	Buy	+343,000	New	+$12.6M	1.35%	27
2020 Q3	–	Sell	-716,720	Closed	-$22.2M	–	12
2020 Q2	$22.2M	Buy	+716,720	New	+$24.3M	9.32%	5
2019 Q1	–	Sell	-548,080	Closed	-$22.7M	–	51
2018 Q4	$22.7M	Buy	+548,080	New	+$22.8M	2.16%	17

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Voleon Capital Management's PFE Position: Q1 2026 in Review

Voleon Capital Management increased its Pfizer (PFE) stake by 6% in Q1 2026, buying an estimated $25.8K and bringing the position to 17,061 shares worth $479K. The position accounts for 0.01% of the portfolio, ranked #584.

Voleon Capital Management first reported a position in PFE in Q4 2018 and has held it in 9 quarters since. The position peaked at $22.7M in Q4 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Voleon Capital Management held 17,061 shares of Pfizer worth $479K as of Q1 2026.
Voleon Capital Management bought 969 Pfizer shares in Q1 2026, an estimated $25.8K.
Pfizer made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #584 holding.
Voleon Capital Management first reported a position in Pfizer in Q4 2018 and has held it in 9 quarters since.
Voleon Capital Management's Pfizer position peaked at $22.7M in Q4 2018.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.